|
Data of homocysteine metabolism parameters of study group and control subjects. |
|||
| Test (unit of measurement) |
RVO subjects (69) |
GC subjects (50) |
P |
|
|
|||
| Hcy (nmol/ml) |
14.7 ± 9.9 |
10.2 ± 8 |
0.02 |
| PL-Hcy (nmol/ml) |
42.7 ± 23.7 |
30.4 ± 13.3 |
<0.01 |
| Δ-tHcy (nmol/ml) |
27.8 ± 21.5 |
21.0 ± 16.0 |
<0.01 |
| Serum folic acid (ng/ml) |
6.27 ± 3.8 |
7.22 ± 3.5 |
Ns |
| Serum B12 vit. (pg/ml) |
403.3 ± 202.0 |
601.6 ± 145.4 |
Ns |
| MTHFR C677T heterozigosity (%) |
46,7 |
56,25 |
Ns |
| MTHFR C677T homozigosity (%) |
29,3 |
4,17 |
<0.01 |
|
Hcy: homocysteine PL-Hcy, post load homocysteine Δ-tHcy: total homocysteine increase MTHFR: methylene tetra hydrofolate reductase RVO: retinal vein occlusion CG: control group Ns: not significant | |||
Ferrazzi et al. Thrombosis Journal 2005 3:13 doi:10.1186/1477-9560-3-13 |
|||